1, –, 3). Dysregulation of DNA methylation is a hallmark of many cancers, and UHRF1 has been suggested as a target for anti-cancer therapy (2, 4). It is overexpressed in multiple cancer lines (5, 6) and thought to play a critical role in the down-regulation of tumor suppressor proteins (2). This evidence concerns the gene TCHP and cancer.